Tolerance is the key to understanding antimalarial drug resistance
- 1 February 2006
- journal article
- review article
- Published by Elsevier BV in Trends in Parasitology
- Vol. 22 (2), 71-77
- https://doi.org/10.1016/j.pt.2005.12.011
Abstract
No abstract availableThis publication has 44 references indexed in Scilit:
- Coartem (Artemether‐Lumefantrine) in Africa: The Beginning of the End?The Journal of Infectious Diseases, 2005
- In Vivo Selection ofPlasmodium falciparum pfmdr186N Coding Alleles by Artemether‐Lumefantrine (Coartem)The Journal of Infectious Diseases, 2005
- Intercontinental Spread of Pyrimethamine-Resistant MalariaScience, 2004
- How species evolve collectively: implications of gene flow and selection for the spread of advantageous allelesMolecular Ecology, 2004
- Estimating the needs for artesunate-based combination therapy for malaria case-management in AfricaTrends in Parasitology, 2003
- The evolution of drug–resistant malaria: the role of drug elimination half–lifePhilosophical Transactions Of The Royal Society B-Biological Sciences, 2002
- Modelling a Predictable Disaster:: The Rise and Spread of Drug-resistant MalariaParasitology Today, 2000
- Multigenic drug resistance among inbred malaria parasitesProceedings Of The Royal Society B-Biological Sciences, 1997
- Strategies for the prevention of antimalarial drug resistance: Rationale for combination chemotherapy for malariaParasitology Today, 1996
- Why do some African children develop severe malaria?Parasitology Today, 1991